title: Screening for people with glucose metabolism disorders within the framework of the DEMOJUAN project (DEMOnstration area for primary prevention of type 2 diabetes, JUAN Mina and Barranquilla, Colombia).
abstract: BACKGROUND
  Until now, no systematic screening for T2D or prevention activities targeting T2D has been implemented in Colombia. The aims of this study were i) describe the feasibility of implementing the Finnish Diabetes Risk Score (FINDRISC) as a screening tool for glucose metabolism disorders (GMD) in the primary health care system in Barranquilla in Colombia during 2011 and 2012, and ii) to describe the risk factors for T2D in the population screened.
  
  
  METHODS
  This screening was opportunistic among people aged 34-60 years living in five primary health care catchment areas in Barranquilla, Colombia. People with 13 or more FINDRISC points were invited to an oral glucose tolerance test (OGTT).
  
  
  RESULTS
  Out of 14193 participants with the FINDRISC completed, 35% (n=4915) had a score of 13 points or higher (men 23%, women 40%). Among those with FINDRISC completed, the percentage of people with BMI<25 kg/m2was 46% in men and 35% in women. The prevalence of screen-detected T2D was 18% in men and 12% in women, respectively, among those with FINDRISC >12 attending an OGTT. In both sexes the prevalence of isolated IGT, isolated IFG, and IFG and IGT combined were 8%, 11%, and 8%, respectively.
  
  
  CONCLUSIONS
  In total, 2% of all 14 193 screened participants had undetected T2D and 7% GMD. This figure would potentially be 4.6% (T2D), respectively 15% (GMD) if all with a FINDRISC>12 attend the OGTT. Thus, we found the FINDRISC to be a useful tool to identify people with GMD. This article is protected by copyright. All rights reserved.
authors.affiliation: Centro de Investigación Sanitaria (CIIS LTDA), Barranquilla, Colombia; University of Tolima, Colombia; HJELT institute, University of Helsinki, Finland.
authors.forename: Noël C
authors.initials: NC
authors.lastname: Barengo
authors.forename: Tania
authors.initials: T
authors.lastname: Acosta
authors.forename: Astrid
authors.initials: A
authors.lastname: Arrieta
authors.forename: Carlos
authors.initials: C
authors.lastname: Ricaurte
authors.forename: Diana
authors.initials: D
authors.lastname: Mayor
authors.forename: Jaakko O
authors.initials: JO
authors.lastname: Tuomilehto
keywords: glucose metabolism disorders; population; screening; type 2 diabetes